RNasin(R) Plus RNase Inhibitor, 10,000u

The University of Virginia has awarded contract A207_PO-0331424-V3 to Promega Corporation for the supply of laboratory reagents. The contract was executed on October 10, 2026, with a cumulative value of $379. The primary deliverable under this purchase order is RNasin Plus RNase Inhibitor, a ribonuclease inhibitor used in molecular biology applications, specified at a concentration of 10,000 units per unit. The contract calls for delivery of 379 units of this product at a unit price of $1.00 per unit.

The contracting organization, the University of Virginia, serves as the buyer and receiving entity for this procurement. As a Virginia-based higher education institution, the university procured this specialized molecular biology reagent for research or laboratory operations. The straightforward unit pricing structure and modest aggregate contract value suggest this represents a routine procurement of standard laboratory consumables by Promega Corporation, an established supplier of life science research products.